Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115353033 | 11535303 | 3 | F | 20140528 | 20160914 | 20150922 | 20160919 | EXP | US-009507513-1509USA010632 | MERCK | 0.00 | M | Y | 68.27000 | KG | 20160919 | LW | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115353033 | 11535303 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | 59900 | MG | 21995 | 100 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115353033 | 11535303 | 1 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
115353033 | 11535303 | HO |
115353033 | 11535303 | DE |
115353033 | 11535303 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115353033 | 11535303 | Acute hepatic failure | |
115353033 | 11535303 | Acute kidney injury | |
115353033 | 11535303 | Adenocarcinoma pancreas | |
115353033 | 11535303 | Aortic valve calcification | |
115353033 | 11535303 | Atelectasis | |
115353033 | 11535303 | Atrial fibrillation | |
115353033 | 11535303 | Bile duct obstruction | |
115353033 | 11535303 | Blood calcium decreased | |
115353033 | 11535303 | Blood glucose decreased | |
115353033 | 11535303 | Cardiomegaly | |
115353033 | 11535303 | Cholelithiasis | |
115353033 | 11535303 | Chronic kidney disease | |
115353033 | 11535303 | Constipation | |
115353033 | 11535303 | Cystitis escherichia | |
115353033 | 11535303 | Death | |
115353033 | 11535303 | Duodenal ulcer | |
115353033 | 11535303 | End stage renal disease | |
115353033 | 11535303 | Hyperlipidaemia | |
115353033 | 11535303 | Hypertension | |
115353033 | 11535303 | Hypokalaemia | |
115353033 | 11535303 | Hyponatraemia | |
115353033 | 11535303 | Leukocytosis | |
115353033 | 11535303 | Malnutrition | |
115353033 | 11535303 | Metabolic acidosis | |
115353033 | 11535303 | Mitral valve disease | |
115353033 | 11535303 | Normochromic normocytic anaemia | |
115353033 | 11535303 | Oesophageal candidiasis | |
115353033 | 11535303 | Orchitis | |
115353033 | 11535303 | Pulmonary hypertension | |
115353033 | 11535303 | Renal tubular necrosis | |
115353033 | 11535303 | Rhabdomyolysis | |
115353033 | 11535303 | Tricuspid valve incompetence | |
115353033 | 11535303 | Urinary tract infection fungal | |
115353033 | 11535303 | Ventricular tachycardia | |
115353033 | 11535303 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
115353033 | 11535303 | 1 | 20121008 | 20140529 | 0 |